BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2837386)

  • 1. Correlation between serum enzymes and serum unsaturated vitamin B12 binding proteins in primary liver carcinoma.
    Osifo BO; Ayoola A; Parmentier Y; Gerard P; Nicolas JP
    Enzyme; 1988; 39(3):161-6. PubMed ID: 2837386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcobalamin I as a "marker" for fibrolamellar hepatoma.
    Wheeler K; Pritchard J; Luck W; Rossiter M
    Med Pediatr Oncol; 1986; 14(4):227-9. PubMed ID: 3018464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated serum vitamin B12 in cystic fibrosis.
    Lindemans J; Abels J; Neijens HJ; Kerrebijn KF
    Acta Paediatr Scand; 1984 Nov; 73(6):768-71. PubMed ID: 6524365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin B12 binding protein as a tumour marker for hepatocellular carcinoma.
    Kane SP; Murray-Lyon IM; Paradinas FJ; Johnson PJ; Williams R; Orr AH; Kohn J
    Gut; 1978 Dec; 19(12):1105-9. PubMed ID: 84776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated alpha-fetoprotein levels in hepatocellular carcinoma.
    Yao FY
    Am J Gastroenterol; 1999 Nov; 94(11):3387. PubMed ID: 10566766
    [No Abstract]   [Full Text] [Related]  

  • 6. Retrospective evaluation of serum markers APRI and AST/ALT for assessing liver fibrosis and cirrhosis in chronic hepatitis B and C patients with hepatocellular carcinoma.
    Lin CS; Chang CS; Yang SS; Yeh HZ; Lin CW
    Intern Med; 2008; 47(7):569-75. PubMed ID: 18379139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Transcatheter arterial embolization therapy for hepatoma--assessment in blood chemistry (author's transl)].
    Yamada R; Nakatsuka H; Nakamura K; Sato M; Itami M; Kobayashi N; Tamaoka K; Oda J; Minakuchi K; Onoyama Y; Kanno T; Marumo T; Monna T; Yamamoto S
    Nihon Shokakibyo Gakkai Zasshi; 1981 Feb; 78(2):214-21. PubMed ID: 6264184
    [No Abstract]   [Full Text] [Related]  

  • 8. The value of liver function tests in hepatocellular carcinoma.
    Lopez JB; Balasegaram M; Thambyrajah V; Timor J
    Malays J Pathol; 1996 Dec; 18(2):95-9. PubMed ID: 10879229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proceedings: Primary liver cancer. A review of the clinical features, blood groups, serum enzymes, therapy, and survival of 65 cases.
    al-Sarraf M; Go TS; Kithier K; Vaitkevicius VK
    Cancer; 1974 Feb; 33(2):574-82. PubMed ID: 4360057
    [No Abstract]   [Full Text] [Related]  

  • 10. HEPATIC AND SERUM VITAMIN B12 IN ACUTE AND CHRONIC HEPATITIS.
    NELSON RS; DOCTOR VM
    South Med J; 1964 Dec; 57():1432-6. PubMed ID: 14226906
    [No Abstract]   [Full Text] [Related]  

  • 11. Serum glutamic oxalacetic transaminase/glutamic pyruvic transaminase ratios in hepatocellular carcinoma.
    Shimokawa Y; Okuda K; Kubo Y; Kaneko A; Arishima T; Nagata E; Hashimoto M; Sawa Y; Nagasaki Y; Kojiro M; Sakamoto K; Nakashima T
    Cancer; 1977 Jul; 40(1):319-24. PubMed ID: 195707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of serum guanase activity in various liver diseases.
    Shiota G; Fukada J; Ito T; Tsukizawa M; Yamada M; Sato M
    Jpn J Med; 1989; 28(1):22-4. PubMed ID: 2542677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Serum changes in liver metastasizing].
    Seidel W; Wick U
    Bruns Beitr Klin Chir (1971); 1972; 219(6):532-7. PubMed ID: 4635388
    [No Abstract]   [Full Text] [Related]  

  • 14. Protocollagen proline hydroxylase in sera of Ugandans with hepatocellular carcinoma.
    Keiser HR; Vogel CL; Sadikali F
    J Natl Cancer Inst; 1972 Nov; 49(5):1251-5. PubMed ID: 4119495
    [No Abstract]   [Full Text] [Related]  

  • 15. Vitamin B₁₂ and its binding proteins in hepatocellular carcinoma and chronic liver diseases.
    Simonsen K; Rode A; Nicoll A; Villadsen G; Espelund U; Lim L; Angus P; Arachchi N; Vilstrup H; Nexo E; Grønbæk H
    Scand J Gastroenterol; 2014 Sep; 49(9):1096-102. PubMed ID: 24958254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum glutathione S-transferase activity in liver diseases.
    Adachi Y; Horii K; Takahashi Y; Tanihata M; Ohba Y; Yamamoto T
    Clin Chim Acta; 1980 Oct; 106(3):243-55. PubMed ID: 6251985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum activities of lysosomal enzymes in patients with liver cell carcinoma.
    Nagasue N; Inokuchi K; Kanashima R
    Dig Dis Sci; 1982 May; 27(5):454-8. PubMed ID: 6176411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Manifestations and prognosis of carcinoma of the liver.
    Malt RA; Van Vroonhoven TJ; Kakumoto Y
    Surg Gynecol Obstet; 1972 Sep; 135(3):361-4. PubMed ID: 4340970
    [No Abstract]   [Full Text] [Related]  

  • 19. [Serum and tissue GOT GPT activities and GOT isoenzymes in human hepatocellular carcinoma and in 3'-me-dab' induced rat hepatoma (author's transl)].
    Arishima T
    Nihon Shokakibyo Gakkai Zasshi; 1978 Mar; 75(3):324-36. PubMed ID: 207911
    [No Abstract]   [Full Text] [Related]  

  • 20. Transcobalamin-binding capacities in vitamin B12-related diseases.
    MacDonald C; Bessent R; Adams J
    Am J Clin Pathol; 1981 May; 75(5):677-83. PubMed ID: 7234754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.